The Pharmacy Examining Board of Canada (PEBC), in their drive to prove their steadfastness and uphold their national mandate of ensuring that Canadians are served by the best and most qualified pharmacists available, recently announced changes to the PEBC exam pathway for internationally trained pharmacists. These changes were made considering the principles that guide PEBC’s decisions, which include integrity, fairness, transparency, innovation, and collaboration.
After reviewing the exam format and requirements for internationally trained pharmacists seeking to work in Canada, the PEBC concluded the review with a few changes made to the structure and requirements of the exams.
Starting May 13, 2025, eligible international pharmacy graduates will be exempt from taking the Pharmacist Evaluation Exam and can move directly to the Qualifying Exam, reducing redundancy in the pathway. Another change, enacted in June 2025, altered the percentage of question sources and the number of questions asked. This article gives a detailed review of both changes and what they mean for IPGs seeking to migrate to Canada.
The Evaluating Exam
The PEBC Evaluating Exam is a prerequisite for initial registration and licensure as a pharmacist in Canada. The exam assesses an applicant’s knowledge and skills and grants the right to move on to the Qualifying Exam. Historically, this exam has served as a gatekeeper to ensure international pharmacy graduates meet a baseline level of competence before undertaking the qualifying process’s MCQ and OSCE components.
With the 2025 updates, however, the role and format of the Evaluating Exam have been adjusted to better reflect modern-day practice and the shifting landscape of pharmacy education internationally.
What the Evaluating Exam Now Looks Like
Under the revised framework, the Evaluating Exam has been refocused on content that maps directly to entry-level pharmacy practice in Canada. Rather than treating biomedical sciences as a standalone domain, the exam now integrates essential scientific principles into clinically relevant contexts—placing greater emphasis on:
- Pharmaceutical sciences (25%)
- Clinical pharmacy practice (55%)
- Behavioural, social, and administrative aspects of care (20%)
The total number of items has been streamlined, and question distribution realigned. Candidates now face a test that is shorter but more tightly linked to what pharmacists do in practice: evaluating medications, designing therapeutic plans, identifying and managing drug interactions or adverse effects, and communicating effectively with patients and healthcare professionals.
Why This Matters to International Graduates
For internationally trained pharmacists, these changes bring two main outcomes:
- Exam content more closely mirrors the work they will perform in Canadian settings. Study time once spent on basic science recall can now be redirected to case-based reasoning, pharmacotherapeutics, and patient-centred decision-making.
- Because the Evaluating Exam’s function has been narrowed—and the new Streamlined Pathway allows eligible applicants to bypass it—certain pharmacists with equivalent credentials and recent practice experience can progress faster toward licensure.
The Streamlined Pathway: Who Benefits and How It Works
Introduced in mid-May 2025, the Streamlined Pathway is the most significant operational change PEBC announced. It recognises that some international programs and jurisdictions maintain standards comparable to Canada’s, and that repeating another assessment can cause unnecessary delay and cost.
Eligible candidates—those whose education, accreditation status, or recent practice meet PEBC’s criteria—may now move directly to the Qualifying Examination Part I (MCQ), provided their documentation is verified and all administrative requirements are met.
PEBC has outlined two main routes to qualify:
- Based on the accreditation status of the graduate’s pharmacy program
- Based on recent, full, unrestricted licensure plus practice in jurisdictions with comparable regulatory frameworks
Candidates should carefully review the board’s guidelines and, where needed, provide clear documentary evidence of accreditation or practice history.
Preparing for the Qualifying Exams Under the New Pathway
For those who qualify for the Streamlined Pathway, preparation shifts immediately toward the Qualifying Exam blueprint.
- Part I (MCQ): Assesses applied clinical knowledge and decision-making. Success is required before attempting Part II.
- Part II (OSCE): Evaluates hands-on clinical skills, communication, and professional behaviours.
Prospective candidates should focus preparation on clinical therapeutics, the patient-care process, case-based problem solving, and simulated patient interactions. High-yield areas include pharmacotherapy across major disease states, safe prescribing, monitoring strategies, patient counselling, and jurisdiction-specific topics such as controlled substances regulation, public health, and scope of practice.
For Candidates Still Taking the Evaluating Exam
Not every internationally trained pharmacist will qualify for the Streamlined Pathway. For those in the traditional track, the June 2025 blueprint is important.
Since biomedical content is no longer a separate category, study strategies should focus on integrated clinical application rather than memorization of basic science facts. Candidates should align their revision with the new subject weightings—placing more time on pharmaceutical sciences and pharmacy practice, while also preparing for behavioural and administrative science issues that influence patient safety and outcomes.
Practical Exam-Taking Guidance
Across both pathways, the basics of strong exam technique remain critical:
- Read clinical vignettes carefully, noting comorbidities, age, renal or hepatic function, pregnancy status, and allergies.
- Be precise with doses and routes—avoid ranges unless specified.
- Provide only the number of answers requested.
- If no treatment is indicated, state so clearly.
- Use generic drug names whenever possible.
- Keep patient communication clear and actionable in counselling-style questions.
Systemic and Professional Implications
PEBC’s revisions are not merely administrative; they reflect evolving expectations around competency and public protection. By recognising comparable international training and recent practice, the board aims to maintain high standards while reducing unnecessary barriers to workforce entry—an important consideration in the context of pharmacy workforce planning and health-system demands.
At the same time, the rebalanced Evaluating Exam blueprint and the emphasis on behavioural and social determinants of health point to a profession increasingly attentive to equity, cultural safety and interprofessional collaboration. These are not peripheral topics: regulators and employers alike are placing increased value on clinicians who can navigate complex social contexts and work effectively in diverse healthcare teams.
Actionable Checklist for Candidates
- Confirm your status: Use PEBC’s published criteria to determine whether you might qualify for the Streamlined Pathway. Gather program accreditation documentation or proof of recent, full licensure and practice where applicable.
- Complete document verification: Ensure your transcripts, licenses and other documents are submitted and verified early. There are bound to be administrative delays so it would be best to get ahead of the curve by applying early.
- Select your study target: If you qualify for the streamlined route, prioritize Part I (MCQ) materials and practice items. If not, align study time with the updated Evaluating Exam blueprint. Thankfully, CanadQbank stays current with the latest changes made by the PEBC, as our Qbanks reflect real-time decisions.
- Practice OSCE-style skills: Even if you begin with the MCQ, part of the qualifying sequence is the OSCE; work on patient communication, counselling scripts, and problem-solving under time pressure.
- Monitor timelines and sittings: PEBC has adjusted scheduling to reflect increased demand; keep an eye on application windows and test dates so you can secure your preferred administration.
- Network and seek mentorship: Connect with peers who have recently completed the pathway or with professional groups for internationally trained pharmacists; they can serve as a fount of invaluable practical tips and moral support.